Ram H. Nagaraj

4.6k total citations
102 papers, 3.9k citations indexed

About

Ram H. Nagaraj is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Ram H. Nagaraj has authored 102 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 63 papers in Clinical Biochemistry and 29 papers in Physiology. Recurrent topics in Ram H. Nagaraj's work include Advanced Glycation End Products research (63 papers), Connexins and lens biology (57 papers) and Biochemical effects in animals (26 papers). Ram H. Nagaraj is often cited by papers focused on Advanced Glycation End Products research (63 papers), Connexins and lens biology (57 papers) and Biochemical effects in animals (26 papers). Ram H. Nagaraj collaborates with scholars based in United States, Germany and India. Ram H. Nagaraj's co-authors include Vincent M. Monnier, Rooban B. Nahomi, Mikhail Linetsky, Manjunatha B. Bhat, Cibin T. Raghavan, Marcus A. Glomb, Tomoko Oya‐Ito, David R. Sell, Fumitaka Hayase and Satoshi Miyata and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Ram H. Nagaraj

100 papers receiving 3.8k citations

Peers

Ram H. Nagaraj
Timothy Slattery United States
Susan P. LeDoux United States
Harry M. Lander United States
Mei Du United States
Subbiah Pugazhenthi United States
Ram H. Nagaraj
Citations per year, relative to Ram H. Nagaraj Ram H. Nagaraj (= 1×) peers Sookja Kim Chung

Countries citing papers authored by Ram H. Nagaraj

Since Specialization
Citations

This map shows the geographic impact of Ram H. Nagaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ram H. Nagaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ram H. Nagaraj more than expected).

Fields of papers citing papers by Ram H. Nagaraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ram H. Nagaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ram H. Nagaraj. The network helps show where Ram H. Nagaraj may publish in the future.

Co-authorship network of co-authors of Ram H. Nagaraj

This figure shows the co-authorship network connecting the top 25 collaborators of Ram H. Nagaraj. A scholar is included among the top collaborators of Ram H. Nagaraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ram H. Nagaraj. Ram H. Nagaraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Peter S., Cole R. Michel, Rooban B. Nahomi, et al.. (2024). Quantifying Protein Acetylation in Diabetic Nephropathy from Formalin‐Fixed Paraffin‐Embedded Tissue. PROTEOMICS - CLINICAL APPLICATIONS. 18(6). e202400018–e202400018. 1 indexed citations
2.
Nam, Mi-Hyun, et al.. (2024). Peptain-1 blocks ischemia/reperfusion-induced retinal capillary degeneration in mice. Frontiers in Cellular Neuroscience. 18. 1441924–1441924. 2 indexed citations
3.
Panja, Sudipta, Rooban B. Nahomi, Johanna Rankenberg, et al.. (2023). Aggrelyte‐2 promotes protein solubility and decreases lens stiffness through lysine acetylation and disulfide reduction: Implications for treating presbyopia. Aging Cell. 22(4). e13797–e13797. 11 indexed citations
4.
Panja, Sudipta, et al.. (2023). Topical ocular application of aggrelyte-2A reduces lens stiffness in mice. SHILAP Revista de lepidopterología. 3. 1274825–1274825. 5 indexed citations
5.
Rankenberg, Johanna, Stefan Rakete, Brandie D. Wagner, et al.. (2021). Advanced glycation end products in human diabetic lens capsules. Experimental Eye Research. 210. 108704–108704. 16 indexed citations
6.
Nandi, Sandip K., Johanna Rankenberg, Stefan Rakete, et al.. (2020). Glycation-mediated protein crosslinking and stiffening in mouse lenses are inhibited by carboxitin in vitro. Glycoconjugate Journal. 38(3). 347–359. 7 indexed citations
7.
Nahomi, Rooban B., Sandip K. Nandi, & Ram H. Nagaraj. (2019). A monoclonal antibody targeted to the functional peptide of αB-crystallin inhibits the chaperone and anti-apoptotic activities. Journal of Immunological Methods. 467. 37–47. 3 indexed citations
8.
Raghavan, Cibin T. & Ram H. Nagaraj. (2016). AGE-RAGE interaction in the TGFβ2-mediated epithelial to mesenchymal transition of human lens epithelial cells. Glycoconjugate Journal. 33(4). 631–643. 27 indexed citations
9.
Nahomi, Rooban B., et al.. (2014). Deletion of IDO prevents diabetes-induced retinal capillary degeneration in mice. Investigative Ophthalmology & Visual Science. 55(13). 5830–5830. 1 indexed citations
10.
Nahomi, Rooban B., et al.. (2013). Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(2). 164–174. 42 indexed citations
11.
Nahomi, Rooban B., Tomoko Oya‐Ito, & Ram H. Nagaraj. (2012). The combined effect of acetylation and glycation on the chaperone and anti-apoptotic functions of human α-crystallin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1832(1). 195–203. 31 indexed citations
12.
Uchiki, Tomoaki, Karen Weikel, Wangwang Jiao, et al.. (2011). Glycation‐altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age‐related disease (in nondiabetics). Aging Cell. 11(1). 1–13. 156 indexed citations
13.
Nagaraj, Ram H., Rooban B. Nahomi, Mikhail Linetsky, et al.. (2011). Acetylation of αA-crystallin in the human lens: Effects on structure and chaperone function. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(2). 120–129. 61 indexed citations
14.
Linetsky, Mikhail, Kaid Johar, Jasmin Meltretter, et al.. (2011). Determination of dideoxyosone precursors of AGEs in human lens proteins. Archives of Biochemistry and Biophysics. 514(1-2). 16–26. 3 indexed citations
15.
Gangadhariah, Mahesha, Benlian Wang, Mikhail Linetsky, et al.. (2010). Hydroimidazolone modification of human αA-crystallin: Effect on the chaperone function and protein refolding ability. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(4). 432–441. 31 indexed citations
16.
Pasupuleti, Nagarekha, et al.. (2010). The role of the cysteine residue in the chaperone and anti‐apoptotic functions of human Hsp27. Journal of Cellular Biochemistry. 110(2). 408–419. 27 indexed citations
17.
Biswas, Ashis, Benlian Wang, Masaru Miyagi, et al.. (2008). Chemical Modulation of the Chaperone Function of Human αA-Crystallin. The Journal of Biochemistry. 144(1). 21–32. 16 indexed citations
18.
Nagaraj, Ram H., Tomoko Oya‐Ito, Manjunatha B. Bhat, & Bing-Fen Liu. (2005). Dicarbonyl Stress and Apoptosis of Vascular Cells: Prevention by αB‐Crystallin. Annals of the New York Academy of Sciences. 1043(1). 158–165. 31 indexed citations
19.
Liu, Bing-Fen, Manjunatha B. Bhat, & Ram H. Nagaraj. (2004). αB-crystallin inhibits glucose-induced apoptosis in vascular endothelial cells. Biochemical and Biophysical Research Communications. 321(1). 254–258. 37 indexed citations
20.
Monnier, Vincent M., Ram H. Nagaraj, Manuel Portero-Otı́n, et al.. (1996). Structure of advanced Maillard reaction products and their pathological role. Nephrology Dialysis Transplantation. 11(supp5). 20–26. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026